Daily filing brief

10 Most Important Filings — 8 August 2026

A concise list of today's most consequential exchange filings, selected for relevance and impact.

  1. Krishna Institute of Medical Sciences Ltd10:50 pm IST

    KIMS Hospitals Q1 FY27: revenue 1,180 crore; debt reduced; Kondapur ramp-up and empanelment progress.

    Financial Performance

    • Quarter 1 FY27 consolidated revenue 1,180 crore, up 35.3% YoY.
    • Quarter 1 FY27 EBITDA pre-Ind AS 222 crore, up 14.6% YoY.
    • EBITDA margin 20.1% in Q1 FY27; 20.27% Q1 FY26; 19.9% Q4 FY26.
    • PAT INR 37 crore in Q1 FY27; Q1 FY26 INR 85 crore; Q4 FY26 INR 33 crore.
    • Cash and equivalents INR 505 crore as of 30 Jun 2026.
    • QIP raised INR 1,500 crore; INR 1,100 crore utilized to reduce debt.
    • Promoter preferential allotment INR 600 crore; 25% upfront; balance in 18 months.
    • Debt reduced from INR 3,250 crore (Mar 31, 2026) to around INR 2,400 crore by early July.
    • Kondapur hospital commissioned; first patient admitted June 20; July revenue grew 40%.

    Growth and Capex

    • Palakkad Kerala unit opened; Bengaluru Mahadevapura break-even achieved.
    • Electronic City expected break-even in 1-2 quarters.
    • CAPEX last quarter ~INR 60-75 crore; Rajahmundry capex ~60-75 crore this year.
    • Next nine months CAPEX ~INR 100-125 crore across three assets; Kondapur largely done.
    • O&M agreements with Golden Lane and Sarvottam; 300-bed near Kondapur; revenue potential INR 90-95 crore/month.
    • Empanelment progress: 50% of insurers empanelled; remaining 50% pursued; most by Aug-Sep.
    • Debt-equity target 2.5:1; internal accruals for growth CAPEX.

    Operations and Margin Trajectory

    • Telangana occupancy around 50-52%; Kondapur beds added late; 70% ramp target in 3-4 years.
    • Nashik break-even; Thane margins around 10% in June; improvement expected.
    • Mahadevapura break-even achieved; Electronic City expected break-even by year-end or 1-2 quarters.
    • Bengaluru ARPOB around INR 80,000–85,000; ARPP similar; empanelments will normalize.
    • Kerala margins targeted at 20–22% over 2-3 years; current single-digit.
    • ARPOB growth guidance: 4–5% sustainable; management cautions progress.

    Outlook and Q&A Highlights

    • No formal FY27 guidance yet; focus on stabilizing current hospitals.
    • Kondapur revenue potential around INR 1,200 crore annually (~INR 100 crore/month).
    • Other expansion plans depend on empanelments; potential greenfield/brownfield in core markets.
    • Old Kondapur rentals ~INR 90 lakhs/month; annual ~INR 12 crore; additional costs ~INR 3–4 crore.
    • O&M deals yield top-line share; P&L impact material only after ramp-up.
    • Common empanelment progress; industry updates expected in coming months.
    Read the original filing
  2. Unimech Aerospace and Manufacturing Ltd4:00 pm IST

    Unimech Aerospace Q1 FY27: Revenue at INR108 crore; Hobel Bellows integration; nuclear orders INR87 crore; capex and QIP plans underway

    Financial Performance

    • Q1 FY27 revenue approximately INR108 crores; 32% sequential growth over Q4 FY26; 71% YoY.
    • Hobel Bellows revenue contributed in two months; total ~INR22 crores.
    • Aero tooling ~76% of revenue; Hobel Bellows ~21%.
    • Gross margin 65%; EBITDA margin approximately 36.5%.
    • PAT around INR28 crores; PAT margin 24%; 46% YoY growth; 7% QoQ.
    • Other income ~INR7 crores; lower than prior quarter due to treasury funds deployed to Hobel Bellows.

    Order Book and Pipeline

    • Consolidated order book including Hobel ~INR280 crores as of 30 June 2026.
    • Nuclear orders INR87 crores; execution planned during the second half of the financial year.
    • FACC Austria long-term supply agreement is USD7.5 million over five years.
    • Hobel Bellows integration progressing; cross-selling to other industries; two new locomotive and power-gen customers onboarding by year-end subject to qualification.

    Capex and Projects

    • No significant core capex planned in FY27; capacity expansion tied to qualification programs.
    • Saudi Arabia JV with Kanoo Group: capex to proceed; gross block by FY27 ~ double; US$10 million infusion into JV this month.
    • AS9100 certification for Vizag facility targeted by Q4 FY27.
    • Free trade warehousing zone fully operational.

    Operational Metrics

    • Utilization ~58%; ~10% of capacity committed to qualification and new product introductions.
    • Working capital days ~130; could rise toward ~160 days by year-end.
    • Finance cost ~INR2 crores; depreciation ~INR8 crores; headcount ~1,232.

    Guidance and Outlook

    • FY27 outlook: expect meaningful consolidated growth; next quarter stronger with higher revenue and robust EBITDA margins.
    • Consolidated gross margin around 65% sustainable; blended EBITDA margin target of 30-32% plus; near-term 34-35% possible.
    • Nuclear and tooling demand pipeline remains strong; more opportunities visible in nuclear tenders.

    Fundraising and Strategic Initiatives

    • Board-approved fundraising up to INR750 crores via QIP to meet minimum public shareholding and capture demand tailwinds.
    • Inorganic growth potential; M&A considered to build capacity as needed.
    • Dheya Engineering Technologies: Unimech to participate in USD10 million equity raise; exclusive manufacturing arrangement unchanged; possible modest dilution.
    • Saudi Kanoo JV expands international manufacturing footprint; localization opportunities in Saudi Arabia.

    Q&A Highlights

    • Nuclear order execution timeline: INR87 crores to be executed in H2 FY27; remaining opportunities later.
    • Hobel contribution: ~INR22 crores revenue in two months; consolidated EBITDA margin 36.5%.
    • Gross margin guidance: around 65% sustainable; FY27 margins around 34-35%.
    • Asset turns and ROCE: current asset turn ~2x; potential 2.5x–3x; ROCE ~20–21% with higher utilization.
    • Leap engine talks confidential; MRO expansion contemplated when opportunities arise.
    • Tooling vs PCA mix: tooling dominates aero engine components; PCA growing with direct OEM engagements.
    Read the original filing
  3. C.E. Info Systems Ltd7:56 pm IST

    MapmyIndia Q1 FY27: Revenue up 14.9% to INR 139.7 crores; EBITDA 40.2% margin; one-time write-off; open order book ~INR 1,750 crores; full-year EBITDA target 35%+.

    Financial performance

    • Q1 FY27 revenue rose 14.9% YoY to INR 139.7 crores; EBITDA INR 56.1 crores (40.2%).
    • PAT rose 8.6% to INR 49.7 crores; PAT margin 31.2%.

    Segment mix

    • Consolidated Q1 revenue split: Map-led INR 98.7 crores; IoT-led INR 41.0 crores.
    • Open order book end-FY26 stood at INR 1,750 crores, up from INR 1,500 crores.

    One-offs and margins

    • One-time government client write-off of INR 4 crores; net P&L impact INR 0.8 crores.
    • EBITDA margin was impacted about 4 percentage points in the quarter.

    Receivables and government exposure

    • FY26 end receivables were about INR 176 crores; government exposure was the majority.
    • Q1 balance sheet details were not disclosed on the call.

    Guidance and outlook

    • Management targets full-year EBITDA margin of 35%+; quarterly margins may vary.

    Strategic direction and international

    • AI-led push; multi-product, multi-industry MAP-led and IoT-led offerings.
    • International expansion ongoing but not material to current P&L.
    Read the original filing
  4. Aditya Birla Fashion and Retail Ltd9:16 pm IST

    ABFRL approves Q1 2026 unaudited standalone and consolidated results; amalgamation and ICRPL stake increase approved

    Financial results

    • Unaudited standalone and consolidated results for quarter ended June 30, 2026 approved.
    • Comparatives restated for June 30, 2025 and March 31, 2026.

    Amalgamation and corporate actions

    • Scheme of amalgamation of Jaypore E-commerce Private Ltd and TG Apparel & Decor Private Limited approved by NCLT.
    • Amalgamation effective August 1, 2026; restatement in standalone results.
    • NCLT order dated July 2, 2026; ROC filing July 10, 2026; subsidiaries dissolved without winding up.
    • Rights issue of 3,65,19,197 equity shares aggregating to 175 crore; ICRPL stake to 89.29%.
    • Subscription completed on May 20, 2026.
    • ESOP allotment: 26,267 equity shares allotted on June 30, 2026.

    Auditor remarks and governance timing

    • Auditors' conclusions not modified despite amalgamation-related restatements.
    • Trading window closed for 48 hours post-announcement.
    Read the original filing
  5. Sportking India Ltd6:02 pm IST

    Sportking India Q1 FY27: strong revenue growth, margin uplift, Odisha expansion on track

    Financial Performance

    • Strong start to FY27 with revenue growth and profitability improvement.
    • Profitability aided by better yarn realizations, export demand, and disciplined raw-material procurement.
    • Input-cost management helped margins despite cotton prices rising.
    • No material contribution from cotton import duty to this quarter.

    Operating Update

    • Cotton yarn realizations improved; global yarn demand recovering.
    • Europe demand improving; UK–India FTA may aid exports later.
    • Export share around 50% of business; China became a larger buyer.
    • Export book maintained at 70–90 days; inventory cycle around 90 days.
    • Odisha greenfield project: 150,000 spindles; Phase 1 production in Q3 FY27.

    Projects and Capex

    • Odisha capex about INR1,000 crores (INR975 crores disclosed); Phase 1 adds 40% capacity.
    • Phase 1 commissioning in next quarter; full project complete within this financial year.
    • Phase 1 EBITDA uplift 300–400 bps versus existing plants.
    • Greenfield output to start contributing in Q4; ramp fully in FY28.
    • Solar project commenced commercial operations; annual savings around INR15 crores.
    • Power-cost savings 12–15% due to renewable energy share.

    Outlook and Guidance

    • FY27 revenue guidance around INR3,000 crores; FY28 around INR4,000 crores.
    • Utilization targeted at 96–97% by start of next financial year.
    • Odisha plant to lift margins; long-term margins stay higher than past levels.
    • Downstream acquisitions to contribute 8–10% topline from next year.
    • Merger via preferential issue; small cash outflow; debt-neutral.
    • US exports not direct; vendors' US lift rising.
    • Middle East demand did not meaningfully affect exports.
    • Odisha subsidies: 30% capex subsidy; INR2.5 per unit power subsidy.
    • Capex plan: INR1,000 crores for Odisha; completed by end of this year.

    Q&A Highlights

    • UK FTA incremental demand seen last month; no orders yet.
    • Odisha ramp-up: 5–6 months to full ramp; 90% utilization by March.
    • Cotton-price volatility; current quarter looks similar or better.
    • China became a buyer; Bangladesh steady; demand outlook supported by FTAs.
    • US tariffs post; not direct; vendor lift rising.
    • Downstream strategy to be shared in 6–8 months; 8–10% topline target.

    Risks and Watchpoints

    • Cotton import duty extension risk; government discussions ongoing.
    • Raw-material price volatility impact on spreads.
    • Execution risk on Odisha project capex and ramp.
    • Dependence on policy environment and FTAs.
    Read the original filing
  6. Amanta Healthcare Ltd10:16 pm IST

    Amanta Healthcare Q1 FY27: Revenue INR 69 cr; SteriPort ~44% of sales; Line 3 and SVP expansion on track

    Financial Performance

    • Q1 FY27 revenue INR 69 crores, up 5% YoY; EBITDA margin ~22%.
    • SteriPort accounts for about 44% of revenue; high-margin product mix supporting profitability.
    • QB: EBITDA INR 15 crores; EBITDA margin remained about 22%.

    Operational Update

    • SteriPort Line 3 commissioning shifted to Q2 FY27 due to civil delays.
    • Capacity rises from 6.6 crore to about 12 crore bottles annually.
    • SVP facility to commence operations in Q4 FY27; first inhalation product mid-September FY27.
    • FDA-approved plans; validation complete by Aug 18; commercial production by last week of August.

    Capex and Projects

    • SteriPort Line 3 capex ~ INR 90 crores; ~INR 80 crores spent so far.
    • SVP capex ~ INR 30 crores; ~INR 7 crores spent; remainder in coming quarters.
    • Solar power: 10.8 MW captive plant commissioned since June 2026; expected to cut power costs.

    Guidance and Outlook

    • Margin expansion target 4-5% including INR 9 crores solar savings.
    • FY27 baseline revenue around INR 370 crores; SteriPort contributes ~INR 70 crores over seven months.
    • FY28 peak revenue ~ INR 425 crores; EBITDA margins ~ 25-26%.
    • SteriPort Line 3 operational by Aug 24-25, 2026; SVP by March FY27.

    Balance Sheet and Cash Flow

    • Debt-to-equity at 1.06; annual debt reduction expected at INR 30-35 crores.
    • Interest expense trending down; FY27 ~ INR 21 crores; FY28 ~ INR 19 crores.

    Q&A Highlights

    • Line 3 annual top-line expected INR 120 crores; seven months contributed ~INR 70 crores.
    • Depreciation from new line ~ INR 4.5 crores annually; total incremental ~ INR 6 crores.
    • ROCE: SteriPort line ~16-17%; SVP ~14-15%.
    • FAT in USA scheduled for November; SVP pipeline includes 20 products; inhalation product commercialized mid-September FY27.
    • R&D: 5 scientists in F&D; 8-10 F&D and 3-4 regulatory staff for advanced markets.
    Read the original filing
  7. Aashka Hospitals Ltd11:46 pm IST

    Aashka Hospitals signs MOU for strategic restructuring to form single entity with 70% stake.

    Parties and purpose

    • Parties: Aashka Hospitals Limited and Rhythm Medical Stores; Rhythm Multispeciality Hospital.
    • Also party: Cardioplus Heart Care; Rhythm Medical & Heart Hospital.
    • Purpose: strategic arrangement to restructure into a single company with Aashka majority stake.

    Key terms

    • Aashka to hold 70% voting rights and capital in the newly emerged company.
    • Aashka to acquire 70% equity shares or voting rights from existing shareholders; price via valuation on transaction date.
    • Post-transaction, Aashka will control the majority of board and decisions.
    • Initial parties are not related to Aashka/promoter group.
    • Post-transaction, the newly emerged entity would be a related party to Aashka.
    • RPT status: not an RPT for this MOU; post-restructuring entity would be related party.
    • No shares issued at present; future issuance subject to valuation.
    • Duration not specified.

    Impact and governance

    • Ownership/control shift: 70% stake to Aashka; majority control.
    • Post-transaction consolidation creates a single entity managing Rhythm group units.
    • No financing terms disclosed.

    Other disclosures

    • Regulatory approvals not specified; filing references Annexure I.
    Read the original filing
  8. Delhivery Ltd11:01 pm IST

    Delhivery elevates Vani Venkatesh to Deputy CEO; Ajith Pai to depart September 2026

    Executive leadership appointments

    • Vani Venkatesh elevated to Deputy CEO, effective immediately.
    • Joined Delhivery February 2025 as Chief Business Officer and KMP.
    • Will lead Revenue, Marketing and Customer Experience with Operations coordination.

    Other governance changes

    • Ajith Pai to move on September 15, 2026 to pursue opportunities.
    • Pai's responsibilities to be transitioned to the new executive operations leadership.
    • Earlier 2026: Varun Bakshi named Chief Sales Officer; other COOs and CPO roles appointed.
    Read the original filing
  9. Apollo Micro Systems Ltd9:38 pm IST

    Apollo Micro Systems to acquire 41.33% Premier Explosives stake; Q1 FY27 revenue up 88.6% YoY

    Business overview

    • Pure-play defence electronics firm focused on indigenous missile programs and DRDO collaborations.
    • Aims to become a Global OEM across land, air, sea over the next decade.
    • Strategic emphasis on R&D, vertical integration, and targeted acquisitions.

    Operational highlights

    • SPA signed July 9, 2026 to acquire 41.33% stake in Premier Explosives Ltd (cash).
    • GOI license to manufacture weapons and ammunitions; MIGM and Limpet Mines entering production.
    • AoN for MIGM accorded by DcPP on 3 July 2026; production phase.
    • Make-II PSO for SAVIOR-ASW awarded by Indian Navy; production to follow.
    • Greenfield expansion to 12x capacity; INR 300 crore capex; 2.47 lakh sq ft land.
    • Export-first trajectory; converting first export order into sustained international revenue.
    • Best quarter in Q1FY27; standalone EBITDA margin 31.0%.

    Financial performance

    • Q1FY27 consolidated revenue from operations Rs 2,512.9 Mn; total revenue Rs 2,535.4 Mn; YoY growth 88.6%.
    • EBITDA (ex Other Income) Rs 537.3 Mn; EBITDA margin 21.4%.
    • PAT Rs 252.2 Mn; PAT margin 10.0%; standalone PAT Rs 278.3 Mn; margin 17.9%.
    • Consolidated borrowings Rs 5,432.6 Mn; cash Rs 1,561.1 Mn; total liabilities Rs 23,685.1 Mn.
    • Cash flow: FY26 operating cash flow -1,297.6 Mn; financing activities 5,358.9 Mn; net cash change 492.3 Mn.
    • Q1FY27 standalone revenue Rs 1,558.9 Mn; PAT Rs 278.3 Mn; EBITDA margin 31.0%.

    Capital structure & liquidity

    • Borrowings rose significantly to Rs 5,432.6 Mn by FY26; no external rating disclosed.
    • Strategic stake purchase increases equity mix; cash portion involved.
    • Liquidity remains positive with cash balance of Rs 1,561.1 Mn.

    Strategic priorities & outlook

    • Vision 2036: become a global OEM with revenues across land, air, sea.
    • Pursue inorganic growth via acquisitions to expand value chain.
    • Develop autonomous weapons and platforms; continue R&D in RF, AI, autonomy, INS.
    • Greenfield expansion supports scaling to 12x capacity; large capex and land bank.
    • Export growth to sustain international revenue stream.

    Risks

    • Industry features high entry barriers; reliance on DRDO programs and ToT; regulatory needs.
    • Regulatory/export controls; long development cycles; mitigated by in-house manufacturing and diversified portfolio.

    Governance & leadership

    • MD: Karunakar Reddy Baddam; WTD Operations: Addepalli Krishna Sai Kumar; WTD Technical: Chandrapati Venkata Siva Prasad.
    • MoUs with BEL, Munitions India, IIT Chennai, and Indian Navy; strategic collaborations.
    • Premier Explosives stake indicates a significant shareholder update.
    Read the original filing
  10. Affle 3I Ltd10:45 pm IST

    Affle reports Q1 FY2027 revenue up 20.4% to INR 747.2 crore; acquires AdColony assets

    Overview

    • Q1 FY2027 consolidated revenue of INR 747.2 crore, up 20.4% YoY.
    • EBITDA of INR 167.6 crore, up 20.0% YoY; EBITDA margin 22.4%.
    • PAT INR 128.4 crore, up 21.7% YoY; PBT INR 157.8 crore, up 22.1%.

    Key financials

    • Revenue: INR 747.2 crore; YoY growth 20.4%; QoQ growth 3.1%.
    • EBITDA: INR 167.6 crore; margin 22.4%.
    • PAT margin 16.6%; PAT INR 128.4 crore.

    Strategic developments

    • Acquired strategic AdColony assets in Q1 FY2027.
    • Strengthened AI-powered Consumer Platform stack for conversions across mobile, CTV and AICDs.
    • CPCU revenue INR 745.5 crore; 20.2% YoY; 12.4 crore converted users in Q1.

    Outlook and guidance

    • Management remains confident in delivering medium-term guidance.
    • Vision of 10x growth remains intact; geographic expansion continues.
    Read the original filing